Key Points – Manulife delivered strong second-quarter growth: APE sales rose 21%, core earnings increased 12%, and core EPS climbed 16%, with core ROE reaching 16.3%.
Asia and wealth management were key contributors, including record Asian earnings and CAD 4 billion in global wealth-management net inflows. – Canada’s sales momentum was offset by claims pressure: Canadian APE sales grew 23%, but core earnings fell 10% because of unfavorable disability and group-insurance claims experience
Management expects insurance experience to trend toward neutral by the end of 2026 and retains the ability to reprice group-insurance policies. – A new long-term-care reinsurance deal reduced risk while capital remained strong: The Munich Re agreement transfers biometric risk on CAD 3.2 billion of reserves, bringing total long-term-care morbidity-risk reduction to 24%. Manulife ended the quarter with a 136% LICAT ratio and returned CAD 1.4 billion to shareholders through dividends and buybacks. – 5 Undervalued Stocks To Secure Your High Yield Portfolio Manulife Financial (NYSE:MFC) reported second-quarter 2026 results marked by double-digit growth in insurance sales, higher core earnings and continued capital returns, while also announcing a third long-term care reinsurance transaction in three years. President and Chief Executive Officer Phil Witherington said annualized premium equivalent, or APE, sales increased 21% from a year earlier, supported by double-digit growth in each insurance segment.
New business contractual service margin rose 16%, while the company’s total CSM balance increased 20%. – 3 High Short Interest Stocks that Investors are Getting Wrong Core earnings rose 12% year over year and core earnings per share increased 16%, helped by ongoing share repurchases. Manulife reported core return on equity of 16.3%, up 130 basis points from the prior-year quarter. Net income totaled CAD 2.1 billion, exceeding core earnings as higher-than-expected public equity returns…